Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Neth J Med ; 69(6): 292-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21868818

ABSTRACT

To reduce unintentional and avoidable adverse events in patients in hospitals in the Netherlands, a patient safety agency (VMS) programme was launched in 2008. Among the VMS topics, the programme 'optimal therapy in severe sepsis', according to the international Surviving Sepsis Campaign (SSC), aims to improve early diagnosis and treatment of sepsis to reduce sepsis mortality by 15% before the end of 2012. We analysed compliance data submitted to the international SSC database from the Netherlands and compared these data with published international SS C results. Data of 863 patients, representing 6% of the international data (n=14,209), were used for analysis. In the Netherlands, the resuscitation bundle compliance improved significantly from 7% at baseline to 27% after two years (p=0.002). Internationally, the resuscitation bundle compliance increased significantly from 11 to 31% (p.


Subject(s)
Hospital Mortality/trends , Patient Safety/standards , Sepsis/diagnosis , Sepsis/therapy , Adult , Early Diagnosis , Guideline Adherence/statistics & numerical data , Health Plan Implementation , Humans , Netherlands/epidemiology , Sepsis/mortality , Survival Analysis
2.
Transfusion ; 44(11): 1567-71, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15504161

ABSTRACT

BACKGROUND: Total knee arthroplasty (TKA) or total hip arthroplasty (THA) regularly results in postoperative requirement of blood transfusion. Because of the disadvantages of allogeneic blood transfusion (ABT) such as the risk of transfusion-associated infections, incompatibility-related transfusion fatalities, or immunomodulatory effects, a continuing effort to reduce allogeneic blood transfusion is important. For this purpose, the effect of reinfusion of drain blood, via a postoperative wound drainage and reinfusion system, on the need for allogeneic blood transfusion was evaluated. STUDY DESIGN AND METHODS: Using a prospective observational quality assessment design, we compared 135 patients scheduled for TKA or THA with a historic group of 96 patients. In the study group the Bellovac ABT autotransfusion system was used. The shed blood was returned either when 500 mL were collected or at most 6 hours after surgery. Compared were the preoperative, postoperative, and discharge hemoglobin, as well as the number of allogeneic blood transfusions. RESULTS: There were no statistical differences between preoperative, postoperative, and discharge hemoglobin levels. Autologous transfusion reduced the number of patients receiving ABT overall from 35 percent (control) to 22 percent (study). The decrease of allogeneic transfusion requirement was most significant after TKA: from 18 percent to 6 percent (p < 0.001). CONCLUSION: We conclude that the Bellovac ABT device reduces allogeneic blood transfusions in TKA and THA.


Subject(s)
Arthroplasty, Replacement, Hip/methods , Arthroplasty, Replacement, Knee/methods , Blood Loss, Surgical , Blood Transfusion, Autologous/methods , Postoperative Care , Blood Transfusion, Autologous/instrumentation , Drainage/instrumentation , Erythrocyte Transfusion , Filtration , Hemoglobins/analysis , Humans , Prospective Studies
3.
Intensive Care Med ; 30(6): 1232-4, 2004 Jun.
Article in English | MEDLINE | ID: mdl-14985956

ABSTRACT

Recombinant factor VIIa (rFVIIa, NovoSeven) has been registered for the treatment of bleeding episodes in patients with inherited or acquired hemophilia A or B with inhibitors. Furthermore, rFVIIa has been used successfully for the treatment of bleeding in patients with thrombocytopenia, and acquired and congenital platelet dysfunction. The definite spectrum of indications for rFVIIa has not yet been established. We describe a case of severe intra-abdominal bleeding 3 days after non-heart beating kidney transplantation in a patient with severe coronary artery disease in which rFVIIa (a single intravenous bolus injection 70 microg/kg bodyweight) was successfully used. No thrombotic complications occurred. This report demonstrates that rFVIIa might be safe and effective after recent renal transplantation.


Subject(s)
Factor VIIa/therapeutic use , Kidney Transplantation , Postoperative Hemorrhage/drug therapy , Recombinant Proteins/therapeutic use , Humans , Male , Middle Aged
4.
Acta Anaesthesiol Scand ; 48(3): 377-8, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14982574

ABSTRACT

Hypoglossal nerve injury is a rare complication of anaesthesia airway management in adults. Until now the use of nitrous oxide for anaesthesia supposedly contributed to this complication. We present a case of bilateral hypoglossal nerve injury following the use of a laryngeal mask airway without the use of nitrous oxide. At the conclusion of 3 h of surgery in extreme side rotation, a 15-year-old boy of 88 kg could not extend his tongue beyond his teeth. An MRI confirmed the absence of pharyngeal haematoma and the absence of thrombosis of the basilar artery. We conclude that even when patients have no medical history and nitrous oxide is not being used, prolongation of the operation in an extreme position might increase the risk of major complications with a laryngeal mask.


Subject(s)
Hypoglossal Nerve Injuries , Laryngeal Masks/adverse effects , Adolescent , Anesthetics, Inhalation/administration & dosage , Anesthetics, Intravenous/administration & dosage , Cicatrix/surgery , Ear, External/surgery , Fentanyl/administration & dosage , Humans , Male , Methyl Ethers/administration & dosage , Nitrous Oxide , Propofol/administration & dosage , Sevoflurane , Speech Disorders/etiology , Tongue/innervation
SELECTION OF CITATIONS
SEARCH DETAIL
...